Insulin Delivery Devices Market Size, Share, and Trends 2024 to 2034

The global insulin delivery devices market size was USD 18.63 billion in 2023, estimated at USD 19.84 billion in 2024 and is anticipated to reach around USD 37.02 billion by 2034, expanding at a CAGR of 6.44% from 2024 to 2034.

  • Last Updated : August 2024
  • Report Code : 1802
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Insulin Delivery Devices Market 

5.1. COVID-19 Landscape: Insulin Delivery Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Insulin Delivery Devices Market, By Type

8.1. Insulin Delivery Devices Market, by Type, 2024-2033

8.1.1. Insulin Pumps

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Insulin Pens

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Insulin Pen needles

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Insulin Jet Injectors

8.1.4.1. Market Revenue and Forecast (2021-2033)

8.1.5. Others

8.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Insulin Delivery Devices Market, By Application

9.1. Insulin Delivery Devices Market, by Application, 2024-2033

9.1.1. Type I Diabetes

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Type II Diabetes

9.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Insulin Delivery Devices Market, By End User 

10.1. Insulin Delivery Devices Market, by End User, 2024-2033

10.1.1. Home Care

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Hospitals & clinics

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Others

10.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Insulin Delivery Devices Market, By Distribution Channels 

11.1. Insulin Delivery Devices Market, by Distribution Channels, 2024-2033

11.1.1. Online Sales

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Hospital Pharmacies

11.1.2.1. Market Revenue and Forecast (2021-2033)

11.1.3. Retail Pharmacies

11.1.3.1. Market Revenue and Forecast (2021-2033)

11.1.4. Others

11.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global Insulin Delivery Devices Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Type (2021-2033)

12.1.2. Market Revenue and Forecast, by Application (2021-2033)

12.1.3. Market Revenue and Forecast, by End User (2021-2033)

12.1.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Type (2021-2033)

12.1.5.2. Market Revenue and Forecast, by Application (2021-2033)

12.1.5.3. Market Revenue and Forecast, by End User (2021-2033)

12.1.5.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Type (2021-2033)

12.1.6.2. Market Revenue and Forecast, by Application (2021-2033)

12.1.6.3. Market Revenue and Forecast, by End User (2021-2033)

12.1.6.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Type (2021-2033)

12.2.2. Market Revenue and Forecast, by Application (2021-2033)

12.2.3. Market Revenue and Forecast, by End User (2021-2033)

12.2.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Type (2021-2033)

12.2.5.2. Market Revenue and Forecast, by Application (2021-2033)

12.2.5.3. Market Revenue and Forecast, by End User (2021-2033)

12.2.5.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Type (2021-2033)

12.2.6.2. Market Revenue and Forecast, by Application (2021-2033)

12.2.6.3. Market Revenue and Forecast, by End User (2021-2033)

12.2.6.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Type (2021-2033)

12.2.7.2. Market Revenue and Forecast, by Application (2021-2033)

12.2.7.3. Market Revenue and Forecast, by End User (2021-2033)

12.2.7.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Type (2021-2033)

12.2.8.2. Market Revenue and Forecast, by Application (2021-2033)

12.2.8.3. Market Revenue and Forecast, by End User (2021-2033)

12.2.8.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Type (2021-2033)

12.3.2. Market Revenue and Forecast, by Application (2021-2033)

12.3.3. Market Revenue and Forecast, by End User (2021-2033)

12.3.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Type (2021-2033)

12.3.5.2. Market Revenue and Forecast, by Application (2021-2033)

12.3.5.3. Market Revenue and Forecast, by End User (2021-2033)

12.3.5.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Type (2021-2033)

12.3.6.2. Market Revenue and Forecast, by Application (2021-2033)

12.3.6.3. Market Revenue and Forecast, by End User (2021-2033)

12.3.6.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Type (2021-2033)

12.3.7.2. Market Revenue and Forecast, by Application (2021-2033)

12.3.7.3. Market Revenue and Forecast, by End User (2021-2033)

12.3.7.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Type (2021-2033)

12.3.8.2. Market Revenue and Forecast, by Application (2021-2033)

12.3.8.3. Market Revenue and Forecast, by End User (2021-2033)

12.3.8.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Type (2021-2033)

12.4.2. Market Revenue and Forecast, by Application (2021-2033)

12.4.3. Market Revenue and Forecast, by End User (2021-2033)

12.4.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Type (2021-2033)

12.4.5.2. Market Revenue and Forecast, by Application (2021-2033)

12.4.5.3. Market Revenue and Forecast, by End User (2021-2033)

12.4.5.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Type (2021-2033)

12.4.6.2. Market Revenue and Forecast, by Application (2021-2033)

12.4.6.3. Market Revenue and Forecast, by End User (2021-2033)

12.4.6.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Type (2021-2033)

12.4.7.2. Market Revenue and Forecast, by Application (2021-2033)

12.4.7.3. Market Revenue and Forecast, by End User (2021-2033)

12.4.7.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Type (2021-2033)

12.4.8.2. Market Revenue and Forecast, by Application (2021-2033)

12.4.8.3. Market Revenue and Forecast, by End User (2021-2033)

12.4.8.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Type (2021-2033)

12.5.2. Market Revenue and Forecast, by Application (2021-2033)

12.5.3. Market Revenue and Forecast, by End User (2021-2033)

12.5.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Type (2021-2033)

12.5.5.2. Market Revenue and Forecast, by Application (2021-2033)

12.5.5.3. Market Revenue and Forecast, by End User (2021-2033)

12.5.5.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Type (2021-2033)

12.5.6.2. Market Revenue and Forecast, by Application (2021-2033)

12.5.6.3. Market Revenue and Forecast, by End User (2021-2033)

12.5.6.4. Market Revenue and Forecast, by Distribution Channels (2021-2033)

Chapter 13. Company Profiles

13.1. Novo Nordisk A/S

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Wockhardt Ltd.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Medtronic

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. F. Hoffmann-La Roche, Ltd.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Abbott Laboratories

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Sanofi

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Eli Lilly and Company

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Biocon Ltd.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Ypsomed AG

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Becton, Dickinson and Company

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client